Janssen adds Hemera’s AMD gene therapy to pipelineJohnson & Johnson’s pharma unit Janssen has bought rights to an investigational gene therapy for a severe form Share XJanssen adds Hemera’s AMD gene therapy to pipelinehttps://pharmaphorum.com/news/janssen-adds-hemeras-amd-gene-therapy-to-ophthalmology-pipeline/
